43LBA Combining genomic profiling (70-gene MammaPrint) with nodal status allows to classifypatients with primary breast cancer and positive lymph nodes (1-9) into very distinct prognostic subgroups that could help tailor treatment strategies.

M.Saghatchian; S.Mook; G.Pruneri; G.Viale; A.Glas; I.Eekhout; S.Delaloge; L.vant Veer

首页> 外文期刊>European Journal of Cancer Supplements >43LBA Combining genomic profiling (70-gene MammaPrint) with nodal status allows to classifypatients with primary breast cancer and positive lymph nodes (1-9) into very distinct prognostic subgroups that could help tailor treatment strategies.

【24h】

43LBA Combining genomic profiling (70-gene MammaPrint) with nodal status allows to classifypatients with primary breast cancer and positive lymph nodes (1-9) into very distinct prognostic subgroups that could help tailor treatment strategies.

机译：43LBA将基因组概况分析（70种基因的MammaPrint）与淋巴结状态相结合，可以将原发性乳腺癌和淋巴结阳性（1-9）的患者分为非常不同的预后亚组，这些亚组可以帮助制定治疗策略。

获取原文

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2009年第3期|共1页
作者
M.Saghatchian; S.Mook; G.Pruneri; G.Viale; A.Glas; I.Eekhout; S.Delaloge; L.vant Veer;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Additional prognostic value of the 70-gene signature (MammaPrint?) among breast cancer patients with 4-9 positive lymph nodes [J] . SaghatchianM., MookS., PruneriG., The Breast : . 2013,第5期

机译：70基因签名（MammaPrint？）在具有4-9个阳性淋巴结的乳腺癌患者中的附加预后价值
2. Economic evaluation of the 70-gene prognosis-signature (MammaPrint?) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan [J] . KondoM., HoshiS.-L., IshiguroH., Breast cancer research and treatment. . 2012,第2期

机译：日本激素受体阳性，淋巴结阴性，人类表皮生长因子受体2型阴性的70基因预后签名（MammaPrint？）的经济评估
3. Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan [J] . Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Breast Cancer Research and Treatment . 2012,第2期

机译：日本激素受体阳性，淋巴结阴性，人类表皮生长因子受体2型阴性的70基因预后签名（MammaPrint ®）的经济评估
4. Ratio Between Positive Lymph Nodes and Total Excised Axillary Lymph Nodes as an Independent Prognostic Factor for Overall Survival in Patients with Nonmetastatic Lymph Node-Positive Breast Cancer [O] . Hassan A. Hatoum, Faek R. Jamali, Nagi S. El-Saghir, 2010

机译：淋巴结阳性和未切除腋窝淋巴结的比率是非转移性淋巴结阳性乳腺癌患者总体生存的独立预后因素
5. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive [O] . Van Calster Ben, Vanden Bempt Isabelle, Drijkoningen Maria, 2009

机译：通过类固醇受体和HER-2联合治疗可手术乳腺癌的腋窝淋巴结状况：三重阳性肿瘤更有可能是淋巴结阳性

43LBA Combining genomic profiling (70-gene MammaPrint) with nodal status allows to classifypatients with primary breast cancer and positive lymph nodes (1-9) into very distinct prognostic subgroups that could help tailor treatment strategies.

著录项

相似文献

相关主题

期刊订阅